Benzinga | May 6, 2021 07:23AM EDT

TherapeuticsMD Q1 EPS $(0.11) Beats $(0.12) Estimate, Sales $19.90M Beat $19.77M Estimate

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 47.62 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $19.90 million which beat the analyst consensus estimate of $19.77 million by 0.66 percent. This is a 62.44 percent increase over sales of $12.25 million the same period last year.